Intractable otitis media with eosinophils: Importance of diagnosis and validity of treatment for hearing preservation

ORL

Volumn 68, Issue 2, 2006, Pages 118-122

  Nakagawa, Takashi ^a   Matsubara, Atsushi ^b   Shiratsuchi, Hideki ^a   Kakazu, Yasuhiro ^a   Nakashima, Torahiko ^a   Koike, Koji ^a   Umezaki, Toshiro ^a   Komune, Shizuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Eosinophils; Hearing loss; Otitis media, intractable

Indexed keywords

ANTIHISTAMINIC AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; STEROID;

ADULT; AGED; ARTICLE; BONE CONDUCTION; CELL DAMAGE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE DURATION; EOSINOPHIL; EOSINOPHILIA; FEMALE; HEARING AID; HEARING LOSS; HUMAN; HUMAN CELL; MALE; MIDDLE EAR; OTITIS MEDIA; PERCEPTION DEAFNESS; PRIORITY JOURNAL;

ADULT; AUDIOMETRY, PURE-TONE; BONE CONDUCTION; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; EOSINOPHILIA; FEMALE; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; MIDDLE AGED; OTITIS MEDIA WITH EFFUSION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 33644879446     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091215     Document Type: Article

References (15)

1. Walsh GM: Advances in the immunobiology of eosinophils and their role in disease. Crit Rev Clin Lab Sci 1999;36:453-496.
2. Koch H: Allergical investigations of chronic otitis. Acta Otolaryngol Suppl 1947;62:1-201.
3. Derlacki EL: Aural manifestations of allergy. Ann Otol Rhinol Laryngol 1952;61:178-188.
4. Ichimiya I, Kawauchi H, Mogi G: Analysis of immunocompetent cells in the middle ear mucosa. Arch Otolaryngol Head Neck Surg 1990; 116:324-330.
5. Hurst DS: Association of otitis media with effusion and allergy as demonstrated by intradermal skin testing and eosinophil cationic protein levels in both middle ear effusions and mucosal biopsies. Laryngoscope 1996;106: 1128-1137.
6. Hurst DS, Weekley M, Ramanarayanan MP: Evidence of possible localized specific immunoglobulin E production in middle ear fluid as demonstrated by ELISA testing. Otolaryngol Head Neck Surg 1999;121:224-230.
7. Iino Y, Nagamine H, Yabe T, Matsutani S: Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma. Clin Exp Allergy 2001;31:1135-1143.
8. Nagamine H, Iino Y, Kojima C, Miyazawa T, Iida T: Clinical characteristics of so called eosinophilic otitis meda. Auris Nasus Larynx 2002;29:19-28.
9. Nonaka M, Fukumoto A, Ozu C, Mokuno E, Baba S, Pawankar R, Yagj T: IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion. Acta Otolaryngol 2003;123:383-387.
10. Robinson DW, Sutton GJ: Age effect in hearing - A comparative analysis of published threshold data. Audiology 1979;18:320-334.
11. Cusimano F, Cocita VC, D'Amico A: Sensorineural hearing loss in chronic otitis media. J Laryngol Otol 1989;103:158-163.
12. Schachern PA, Paparella MM, Goycoolea MV, Duvall AJ III, Choo YB: The permeability of the round window membrane during otitis media. Arch Otolaryngol Head Neck Surg 1987; 113:625-629.
13. Roberts RL, Ank BJ, Stiehm ER: Human eosinophils are more toxic than neutrophils in antibody-independent killing. J Allergy Clin Immunol 1991;87:1105-1115.
14. Alberts WM: Eosinophilic interstitial lung disease. Curr Opin Pulm Med 2004;10:419-424.
15. Aas K: Heterogeneity of bronchial asthma: sub-populations - or different stages of the disease. Allergy 1981;36:3-14.